Jade Biosciences, Inc. Common Stock JBIO Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$40.37M-26.4% | -$31.93M-26.8% | -$25.18M+21.7% | -$32.13M+15.8% | -$38.17M+18.8% | ||
| $9K0.0% | $9K-25.0% | $12K+1,100% | $1K-75.0% | $4K-50.0% | ||
| $7.41M-21.2% | $9.4M+119% | $4.3M+10.3% | $3.9M+60.8% | $2.42M+92.9% | ||
| -$24.08M+28.4% | -$33.65M-52.1% | -$22.12M-9.7% | -$20.16M-7.5% | -$18.76M+17.1% | ||
| —— | $3K-94.7% | $57K-56.5% | $131K+2,520% | $5K— | ||
| -$8.47M+91.4% | -$98.16M+34.0% | -$148.71M-1,045% | -$12.99M-201% | $12.85M-2.1% | ||
| -$795K-100% | $170.16M— | $0-100% | $191.31M+27,430% | -$700K-101% | ||
| -$33.35M-187% | $38.33M+122% | -$170.84M-200% | $171.01M+979% | -$19.46M-128% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Jade Biosciences, Inc. Common Stock generate?
- Jade Biosciences, Inc. Common Stock (JBIO) generated -$100.0M in operating cash flow over the trailing twelve months.
- What is Jade Biosciences, Inc. Common Stock's free cash flow?
- After $196.0K of capital expenditures, Jade Biosciences, Inc. Common Stock's free cash flow was -$94.9M over the trailing twelve months, down 66.7% year over year.
- Where does Jade Biosciences, Inc. Common Stock's cash flow data come from?
- Every line is extracted from Jade Biosciences, Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.